Influence of smoking and smoking cessation on levels of urinary 11-dehydro thromboxane B(2)

BACKGROUND: Thromboxane is a key clinical risk endpoint of smoking-induced inflammation which has been associated in the pathogenesis of cardiovascular disease. The goal of this review is to quantify the effect of smoking and smoking cessation on one of its urinary metabolites, 11-dehydrothromboxane...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Plas, Angela, Pouly, Sandrine, de La Bourdonnaye, Guillaume, Ng, Wee Teck, Baker, Gizelle, Lüdicke, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977536/
https://www.ncbi.nlm.nih.gov/pubmed/29854626
http://dx.doi.org/10.1016/j.toxrep.2018.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977536/
https://www.ncbi.nlm.nih.gov/pubmed/29854626
http://dx.doi.org/10.1016/j.toxrep.2018.04.005

Ejemplares similares